Recombinant Influenza B virus HA and NA antigens administered in equivalent amounts are immunogenically equivalent and induce equivalent homotypic and broader heterovariant protection in mice than conventional and live influenza vaccines
Authors:
- Bert E. JohanssonBJBert E. Johansson
- Ian C. BrettIBIan C. Brett
- 1 November 2008
- journal article
- research article
- Published by Taylor & Francis in Human Vaccines
- Vol. 4 (6) , 420-424